Multiple Myeloma

News

Ixazomib improves PFS after ASCT in MM

SAN DIEGO—Ixazomib improved progression-free survival (PFS) following autologous stem cell transplant (ASCT) in patients with newly diagnosed...

MD IQ

News

Haplo-HSCT feasible in multiple myeloma

A retrospective study suggests haploidentical hematopoietic stem cell transplant (haplo-HSCT) is feasible in patients with multiply relapsed or...

Pages